XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 29, 2018
Sep. 30, 2017
Sep. 29, 2018
Sep. 30, 2017
Operating Activities        
Earnings (loss) $ (4,536) $ (5,883) $ (12,124) $ (17,169)
Items not affecting cash        
Depreciation and amortization 8,171 8,254 24,501 24,601
Amortization of Debt Issuance Costs 598 613 1,806 1,751
Deferred income taxes (1,706) (3,425) (3,857) (13,340)
Stock-based compensation 2,120 1,995 6,395 4,133
Unrealized Loss (Gain) on Derivatives Instrument 2,110 754 867 (475)
Fair Value of Contingent Consideration 25 83 (2,348) 287
Impairment of long-lived assets 0 4,467 409 8,190
Other 36 55 (111) (46)
Changes in non-cash working capital, net of business acquired 3,664 (18,006) (31,771) (25,319)
Net Cash Provided by (Used in) Operating Activities, Total 10,482 (11,093) (16,233) (17,387)
Investing activities        
Purchases of property, plant and equipment (7,758) (6,527) (24,921) (22,694)
Proceeds From Sale Of Property Plant And Equipment 707 475 1,437 776
Payment On Note Receivable From Sale of Business 1,006 39 1,236 39
Minority Interest Decrease From Redemptions 0 (1,737) 0 (1,737)
Other 0 (34) 159 330
Net cash flows from investing activities (6,045) (7,784) (22,089) (23,286)
Financing activities        
Increase (decrease) under line of credit facilities (2,716) 19,222 47,478 48,571
Borrowings under long term debt 0 417 0 417
Repayment of long-term debt (557) (564) (1,494) (1,680)
Payments Of Dividends (1,700) (1,700) (5,100) (4,991)
Proceeds From Stock Options Exercised 359 1,052 599 4,681
Payment of contingent consideration 0 0 (4,399) (4,330)
Financing costs 0 (206) 0 (206)
Other (44) 13 (89) (290)
Net Cash Provided By (Used In) Financing Activities (4,658) 18,234 36,995 42,172
Foreign exchange gain (loss) on cash held in a foreign currency (9) 41 (44) 105
Increase (decrease) in cash and cash equivalents during the period (230) (602) (1,371) 1,604
Discontinued operations cash activity included above:        
Cash and cash equivalents - beginning of the period 2,087 3,457 3,228 1,251
Cash and cash equivalents - end of the period 1,857 2,855 1,857 2,855
Noncash Investing And Financing Items [Abstract]        
Accrued Dividends $ (1,700) $ (1,700) $ (1,700) $ (1,700)